CimCure

Amsterdam, The Netherlands

CimCure focuses on design and development of a novel class of active cancer immunotherapies.

$5.3M raised

Jun 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CimCure raised?

CimCure has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in June 2022.

Who are CimCure's investors?

CimCure's investors include Positron Ventures, Tom Würdinger.

Where is CimCure headquartered?

CimCure is headquartered in Amsterdam, The Netherlands.

What does CimCure do?

CimCure focuses on design and development of a novel class of active cancer immunotherapies.

What stage is CimCure at?

CimCure is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 7, 2022.

MLA

"CimCure — Funding & Investors." VCBacked, June 7, 2022, https://www.vcbacked.co/company/cimcure. Accessed July 2, 2026.

APA

VCBacked. (2022). CimCure — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cimcure

Wikipedia (cite web)

{{cite web |title=CimCure — Funding & Investors |url=https://www.vcbacked.co/company/cimcure |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 7, 2022.